SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALLOCCHIO, Franco Pasquale Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.699
AS - Asia 3.339
EU - Europa 3.260
SA - Sud America 461
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 13
Totale 17.829
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.636
CN - Cina 1.449
SG - Singapore 1.168
UA - Ucraina 910
DE - Germania 694
TR - Turchia 519
BR - Brasile 421
IT - Italia 406
GB - Regno Unito 343
FI - Finlandia 294
SE - Svezia 202
PL - Polonia 106
RU - Federazione Russa 68
CA - Canada 42
FR - Francia 39
HK - Hong Kong 38
IN - India 38
EE - Estonia 36
CZ - Repubblica Ceca 32
NL - Olanda 27
BE - Belgio 25
ZA - Sudafrica 18
JP - Giappone 16
ID - Indonesia 15
IR - Iran 15
AT - Austria 13
IQ - Iraq 13
AR - Argentina 12
MX - Messico 12
BD - Bangladesh 11
ES - Italia 11
LT - Lituania 11
AU - Australia 10
EU - Europa 9
SD - Sudan 9
BG - Bulgaria 8
RO - Romania 8
CL - Cile 6
MY - Malesia 6
UZ - Uzbekistan 6
VN - Vietnam 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CO - Colombia 5
PK - Pakistan 5
CH - Svizzera 4
DK - Danimarca 4
EC - Ecuador 4
EG - Egitto 4
IE - Irlanda 4
KW - Kuwait 4
MA - Marocco 4
PE - Perù 4
TW - Taiwan 4
VE - Venezuela 4
GR - Grecia 3
KR - Corea 3
MT - Malta 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SA - Arabia Saudita 3
UY - Uruguay 3
AZ - Azerbaigian 2
GE - Georgia 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
IL - Israele 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
SV - El Salvador 1
Totale 17.829
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.294
Jacksonville 1.000
Chandler 962
Fairfield 893
Houston 777
Santa Clara 627
Ann Arbor 570
Singapore 537
Ashburn 503
Wilmington 400
Beijing 318
Izmir 303
Seattle 288
Nanjing 286
Cambridge 263
Princeton 209
Dearborn 168
Boardman 165
Ferrara 124
Munich 111
Shenyang 106
Nanchang 105
Warsaw 104
San Diego 99
Shanghai 77
Changsha 69
Milan 69
Addison 61
Tianjin 61
Hebei 59
New York 55
Turku 55
Los Angeles 51
Bremen 49
Jiaxing 47
Helsinki 46
Mountain View 38
Jinan 34
Hong Kong 33
London 33
Ningbo 33
Redwood City 33
São Paulo 33
Orange 30
Kunming 29
Norwalk 27
San Mateo 27
Brno 26
Brussels 23
Düsseldorf 23
San Francisco 20
Zhengzhou 20
Auburn Hills 19
Bologna 19
Washington 19
Brooklyn 18
Guangzhou 18
Hefei 18
Leawood 18
Frankfurt am Main 17
Toronto 16
Augusta 15
Falls Church 15
Indiana 14
Patiala 13
Vienna 13
Curitiba 12
Chicago 11
Falkenstein 11
Fuzhou 11
Haikou 10
Jakarta 10
Philadelphia 10
Phoenix 10
Taizhou 10
Boston 9
Katy 9
Rio de Janeiro 9
Stockholm 9
The Dalles 9
Des Moines 8
Ottawa 8
Porto Alegre 8
Tokyo 8
Verona 8
Amsterdam 7
Ardabil 7
Atlanta 7
Casalecchio Di Reno 7
Changchun 7
Hangzhou 7
Montreal 7
Rome 7
Tappahannock 7
Belo Horizonte 6
Chennai 6
Olomouc 6
Paris 6
Guarulhos 5
Lübeck 5
Totale 11.882
Salva come PNG Salva come JPEG
Nome #
Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase 215
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 175
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 174
6-Phosphogluconate dehydrogenase from Trypanosoma brucei - Kinetic analysis and inhibition by trypanocidal drugs 171
Differentiation between the structural and redox roles of TPNH in 6-phosphogluconate dehydrogenase 160
Role of Methionine 13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 155
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 154
A rapid method for purification of myelin basic protein 149
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 145
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 145
A role for the pyridine nitrogen of reduced triphosphopyridine-nucleotide in the mechanism of action of isocitrate dehydrogenase 144
Activation of the sendai virus fusion protein by receptor binding 143
Identification of the chemical groups involved in the binding of periodate-oxidized NADP+ to 6-phosphogluconate dehydrogenase. 143
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 143
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 141
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies 140
A NEW POWERFUL INHIBITOR SPECIFIC FOR THE TPN BINDING SITE OF 6-PHOSPHOGLUCONATE DEHY DROGENASE 137
Inhibitors of Trypanosoma brucei 6-phosphogluconate dehydrogenase 135
A role for the pyridine nitrogen of reduced triphosphopyridinenucleotide in an enzymatic catalysis 135
Activation of the Sendai virus fusion protein by receptor binding 133
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 132
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 131
Mutual communication of envelope glycoproteins of paramixoviruses 129
null 128
Role of methionine-13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 125
6-phosphogluconate dehydrogenase: structural symmetry and functional asymmetry 124
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 123
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 122
Alkylation of 6-phosphogluconate dehydrogenase from Candida utilis with coenzyme analogues 121
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 119
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 119
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 119
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 119
Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase 118
6-Phosphogluconate dehydrogenase mechanism: Evidence for allosteric modulation by substrate 118
Proper Orientation of the Nicotinamide of NADP is Important for the Pre-catalytic Conformational Change in the 6-Phosphogluconate Dehydrogenase Reaction 117
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 117
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 116
Energy cost for the proper ionization of active site residues in 6-phosphogluconate dehydrogenase from T. brucei 114
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 112
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 112
Isotope effect as a probe of the catalytic rilevance of coenzyme isomerization in the enzyme 6-phosphogluconate dehydrogenase from sheep liver 111
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 111
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 111
NADPH activates a decarboxylation reaction catalysed by lamb liver 6-phosphogluconate dehydrogenase 110
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 110
Dynamics of phosphorus in the Venice lagoon during a picocyanobacteria bloom 109
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 109
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 109
Is there an alternating site co-operativity between the two subunits of lamb liver 6-phosphogluconate dehydrogenase? 108
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 107
Use of Trinitrobenzensulfonate for Affinity Labeling of Lysine Residues at Phosphate Binding Sites of Some Enzymes 107
Analisi della proteina basica della mielina nel liquor 106
Substrate binding to 6-phosphogluconate dehydrogenase 106
null 104
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 104
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 103
null 103
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 102
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 100
X-ray escaping conformational changes affecting enzymatic function 100
Features of hypereutrophic Molino lagoon ecosystem dominated by sedentary polychaetes 100
Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma Brucei 99
6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomiasis 99
X-ray escaping conformational changes affecting enzymatic function 99
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 99
"Do the two subunits of lamb liver 6-phosphogluconate dehydrogenase alternate their role during catalysis?" 98
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 98
Thermodynamic characterization by ITC and DSC of the binding of 4-phospho-d-erythronate to the target enzyme T. brucei 6-phosphogluconate dehydrogenase 97
null 97
Evidence for multiple pairs of vicinal thiols in some proteins 97
Half-site reactivity in 6-phosphogluconate dehydrogenase from human erythrocytes 96
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 96
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 95
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 95
Alternating site catalytic cooperativity in some 6-phosphogluconate dehydrogenases 95
A multiple role for the coenzyme in the mechanism of action of 6-phosphogluconate dehydrogenase 94
Surface mapping of Env protein from HIV by chemical modifications 93
Bromopyruvate for the affinity labelling of a single cysteine residue near the carboxylate binding site of lamb liver 6-phosphogluconate dehydrogenase 93
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 92
Anomeric specificity of the neuraminidase from sendai virus 92
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 91
A new hypothesis on the mechanism of action of lamb liver 6-phosphogluconate dehydrogenase 91
Preliminary cheracterization of recombinant hemagglutinin from Mumps virus 91
Evidences for the proximity of two sulfhydryl groups in the active site of 6-phosphogluconate dehydrogenase 90
Isothermal titration calorimetry tool to better characterize the mechanism of T. brucei 6-phosphogluconate dehydrogenase 89
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 89
A catalytic tyrosine at the active site of sendai virus neuraminidase 88
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 88
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 88
null 88
Biochemical study in adult population with stroke in Ferrara, Fabry disease 87
Selective modification of Sendai virus hemagglutinin neuraminidase by pyridoxal 5'-phosphate: evidence for an allosteric modulation of neuraminidase activity 86
Myelin basic protein inhibits the calcium response to Phytohaemoagglutinin in human lymphocytes 86
Domain structure of the hemagglutinin-neuraminidase from sendai virus 86
Evidence for the proximity of a cysteinyl and a tyrosyl residue in the active sita of 6-phosphogluconate dehydrogenase 85
A further non-redox role for NADPH in the mechanism of action of 6-pho-sphogluconate dehydrogenase from lamb liver 85
o-Phthalaldehyde as a polyfunctional reagent to establish the chemical environment of the nicotinamide moiety of NADP in lamb liver 6-phosphogluconate dehydrogenase 85
Diagnostic value of laboratory tests in Multiple Sclerosis 85
Biochemical characterization of the natural Cys386-FX variant: a new tool to investigate coagulation factor X functions? 84
Totale 11.288
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 423
Totale 91.283
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 0 0 0 34
2020/20212.038 204 207 79 235 56 207 108 246 36 247 332 81
2021/20221.751 33 189 85 68 96 71 36 84 51 177 180 681
2022/20232.055 210 156 54 244 379 290 64 208 251 18 114 67
2023/2024843 93 123 48 30 81 120 16 60 15 15 21 221
2024/20253.715 101 80 335 147 496 266 146 202 542 471 531 398
Totale 18.027